Literature DB >> 3918654

Persistent nephrogenic diabetes insipidus, hyperparathyroidism, and hypothyroidism after lithium treatment.

S R Cairns, R Wolman, J G Lewis, R Thakker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3918654      PMCID： PMC1418021          DOI： 10.1136/bmj.290.6467.516

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Persistent nephrogenic diabetes insipidus associated with long-term lithium carbonate treatment.

Authors:  E Z Rabin; R G Garston; R V Weir; G A Posen
Journal:  Can Med Assoc J       Date:  1979-07-21       Impact factor: 8.262

2.  Lithium and symptomatic hyperparathyroidism.

Authors:  J Ananth; S E Dubin
Journal:  J R Soc Med       Date:  1983-12       Impact factor: 5.344
  2 in total
  4 in total

1.  Prolonged hypernatremia triggered by hyperglycemic hyperosmolar state with coma: A case report.

Authors:  Darlene Vigil; Kavitha Ganta; Yijuan Sun; Richard I Dorin; Antonios H Tzamaloukas; Karen S Servilla
Journal:  World J Nephrol       Date:  2015-05-06

2.  Potentiation of Endocrine Adverse Effects of Lithium by Enalapril and Verapamil.

Authors:  R Krysiak; B Okopien
Journal:  West Indian Med J       Date:  2014-08-29       Impact factor: 0.171

3.  Persistent nephrogenic diabetes insipidus, tubular proteinuria, aminoaciduria, and parathyroid hormone resistance following longterm lithium administration.

Authors:  W D Neithercut; R J Spooner; A Hendry; J H Dagg
Journal:  Postgrad Med J       Date:  1990-06       Impact factor: 2.401

4.  Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus.

Authors:  Soma Jobbagy; Dario A Vitturi; Sonia R Salvatore; Maria F Pires; Pascal Rowart; David R Emlet; Mark Ross; Scott Hahn; Claudette St Croix; Stacy G Wendell; Arohan R Subramanya; Adam C Straub; Roderick J Tan; Francisco J Schopfer
Journal:  JCI Insight       Date:  2020-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.